Exelixis
EXEL
#1304
Rank
A$25.23 B
Marketcap
A$103.42
Share price
2.79%
Change (1 day)
62.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company